On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs ...

AstraZeneca Pharma India rose 1.10% to Rs 10,754 after the firm received approval from the Central Drugs Standard Control Organisation (CDSCO) to import pharmaceutical formulations of eculizumab ...

Eculizumab, a monoclonal antibody, is indicated for the treatment of two rare and life-threatening conditions: Paroxysmal ...

A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by ...

Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...

According to Inan’s team: “There is no documented production process of atezolizumab biosimilar in the literature except one ...

Shares of biotech Summit Therapeutics (NASDAQ: SMMT) skyrocketed 583.7% in 2024, according to data from S&P Global Market ...

The market will grow as a result of the increasing incidence of amyloidosis, technological advancements in diagnostics, ...

Preliminary U.S. BRIUMVI fourth quarter and full year 2024 net product revenue of $103.6 million and $310 million, respectively. Full Year 2025 target total global revenue of appr ...

Request To Download Free Sample of This Strategic Report @ Catalysts of Market Growth: The buoyant growth trajectory of the global monoclonal antibodies market is propelled by a convergence of ...

The Phase Ia trial is designed to assess the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.

Cambridge, Massachusetts Monday, January 13, 2025, 13:30 Hrs [IST] ...